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MRI contrast agents have been widely used to enhance tumor 
detection and improve tumor image quality. Particulate MRI 
contrast agents using conventional proton magnetic resonance 
imaging have met with limited success. Herein, we report a 
process to microencapsulate fluorinated hydrocarbons in a bio- 
compatible protein shell and their efficacy as contrast agents 
for fluorine magnetic resonance imaging ('F M R I ) .  
This techniques allows for the delivery of fluorocarbons 
(e.g., perfluorononane) in a biocompatible form. The 
fluorocarbon containing microcapsules have a narrow size 
distribution with an average diameter of approximately 2 
microns. Upon intravenous injection, the particles are rapidly 
scavenged by the macrophages of the reticuloendothial cell 
(RES)  system. This specific macrophagic uptake introduces 
organ specificity ( e . g . ,  the liver and spleen). 
In vivo I9F MRI and 'H MRI of rats (Fischer 3 4 4 ,  300 9) 
were easily obtained using a 4 . 7  Tesla Oxford superconducting 
magnet. 19F magnetic resonance images of the entire rat as well 
as individual organs such as the liver, spleen and kidney were 
obtained using a TI weighted sequence with TR=1 second, TE=20 
milliseconds and a data matrix of 256x128. 
Overall, excellent quality fluorine images showing liver 
and spleen morphology were obtained demonstrating the potential 
of this technique in the diagnosis and localization of the 
abnormal pathology within the RES containing organs. MR 
imaging with fluorine enables selected areas to be imaged 
without interference or complication from surrounding protons. 
This technique is superior over proton MRI solid or fluid 
microparticles, in that the fluorocarbon-microcapsule itself is 
the source of the MRI signal. The microparticulate contrast 
agents rely only on the distribution of free water and its 
interaction to produce the observed image. 
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